Quick Overview: Arndt Vogel, MD, and Richard Finn, MD, describe Understand the role of IO and IO combinations in the systemic treatment landscape for patients with Experts provide an overview of current systemic treatment
Options In Unresectable Hcc - Detailed Overview & Context
Arndt Vogel, MD, and Richard Finn, MD, describe Understand the role of IO and IO combinations in the systemic treatment landscape for patients with Experts provide an overview of current systemic treatment An examination of surgical candidacy in patients, and an overview of the available treatment Catherine Frenette, MD, reviews a case of a 77-year-old man presenting with Full Podcast: Experts provide an overview of current systemic treatment
In this presentation from the 'Looking Closely at New Therapeutic Dr Richard S. Finn highlights various clinical trials exploring combination immunotherapy regimens for the treatment of ... In this presentation from the Great Debates in Gastrointestinal Malignancies 2018 conference, Dr.Tanios Bekaii-Saab argues in ... Richard D. Kim, MD, Moffitt Cancer Center, Tampa, FL, discusses the results of HIMALAYA, (NCT03298451), an open-label, ... This video is intended for U.S. healthcare professionals only. The content presented in this video is based on information ... George N. Ioannou, MD, associate professor, VA Puget Sound Health Care System, University of Washington School of Medicine, ...
A review of the diagnostic workup for a patient who was subsequently diagnosed with Richard S. Finn, MD, discusses the significance of the results presented on the recent IMbrave150 study in Richard Finn, MD, describes the treatment Andreas Kaubisch, MD, associate attending physician, Montefiore Medical Center, Albert Einstein College of Medicine, discusses ... This OncLive® webinar will focus on best practices and multidisciplinary approaches in the management of
